BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: Between 2020 and 2030, the global home respiratory therapy market is expected to increase at a stable rate.

Tendon is the name given to a fibrous and denser tissue that helps connect the bone to the fleshy muscle and helps in movement to occur simultaneously in the bone and muscle, which aids in walking, bending, and rotation of the muscles and bones.

The world market for dental software is looking to take advantage of the growing adoption of dental practice management software, especially in developed countries such as the U.S.

Mirum Pharmaceuticals, Inc. announced that on January 10, 2022, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 51,700 shares of common stock and 7,150 restricted stock units to five new employees under Mirum’s 2020 Inducement Plan.

Allschwil, Switzerland– January10, 2022 Idorsia Ltd announced that the US Food and Drug Administration has approved QUVIVIQ™ 25 mg and 50 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance1.

Basilea Pharmaceutica Ltd., a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, announced the unaudited preliminary revenue and year-end cash-position for the financial year 2021.

Alcon announced the closing of its previously announced acquisition of Ivantis®, developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery.

Calibre Scientific is pleased to announce the acquisition of Medline Scientific, a distributor of laboratory consumables and equipment with headquarters in Oxfordshire, United Kingdom.

ANGLE plc is pleased to announce that the world-class research team led by Prof. Evi Lianidou at the National and Kapodistrian University of Athens, has published results of a further study undertaken in non-small cell lung cancer patients with an EGFR mutation being treated with the tyrosine kinase inhibitor.

NANOBIOTIX provided a corporate update highlighting key priorities and anticipated development milestones for 2022.